These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 10655054

  • 1. Gene-target recognition among members of the myc superfamily and implications for oncogenesis.
    O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, Meltzer P, DePinho RA.
    Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054
    [Abstract] [Full Text] [Related]

  • 2. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K, Anand G, Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857
    [Abstract] [Full Text] [Related]

  • 3. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L, Rochelle JM, Seldin MF, Skoultchi AI, DePinho RA.
    Oncogene; 1996 Mar 07; 12(5):1165-72. PubMed ID: 8649810
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S, Peña A, Korcz A, Soprano DR, Soprano KJ.
    Oncogene; 1996 Feb 01; 12(3):621-9. PubMed ID: 8637719
    [Abstract] [Full Text] [Related]

  • 5. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B, Larsson LG.
    Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692
    [Abstract] [Full Text] [Related]

  • 6. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N, Chin L, Chen K, Torres R, Thomson CT, Sacchettini JC, DePinho RA.
    Oncogene; 1994 Nov 13; 9(11):3167-77. PubMed ID: 7936639
    [Abstract] [Full Text] [Related]

  • 7. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N, DePinho RA.
    Bioessays; 1998 Oct 13; 20(10):808-18. PubMed ID: 9819568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B, Sommer A, McArthur GA, Eisenman RN, Lüscher B.
    J Cell Physiol; 2000 Jun 13; 183(3):399-410. PubMed ID: 10797315
    [Abstract] [Full Text] [Related]

  • 10. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
    Quéva C, Hurlin PJ, Foley KP, Eisenman RN.
    Oncogene; 1998 Feb 26; 16(8):967-77. PubMed ID: 9519870
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I, Lombard MN, Muñoz-Alonso MJ, Cañelles M, Leon J.
    Mol Carcinog; 2004 Feb 26; 39(2):85-90. PubMed ID: 14750213
    [Abstract] [Full Text] [Related]

  • 12. New Myc-interacting proteins: a second Myc network emerges.
    Sakamuro D, Prendergast GC.
    Oncogene; 1999 May 13; 18(19):2942-54. PubMed ID: 10378691
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ, Arsura M, Bellas RE, Yang W, Wu M, Chin L, Mann KK, DePinho RA, Sonenshein GE.
    Oncogene; 1999 Apr 15; 18(15):2489-98. PubMed ID: 10229200
    [Abstract] [Full Text] [Related]

  • 14. Functions of myc:max in the control of cell proliferation and tumorigenesis.
    Hurlin PJ, Dezfouli S.
    Int Rev Cytol; 2004 Apr 15; 238():183-226. PubMed ID: 15364199
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 16. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE.
    Oncogene; 2001 Mar 29; 20(14):1688-702. PubMed ID: 11313917
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
    Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S.
    Cancer Res; 1998 Aug 15; 58(16):3654-9. PubMed ID: 9721875
    [Abstract] [Full Text] [Related]

  • 18. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ, Halazonetis TD.
    Oncogene; 1993 Jan 15; 8(1):125-32. PubMed ID: 8423990
    [Abstract] [Full Text] [Related]

  • 19. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM, Birnie GD.
    Oncogene; 1997 Jun 12; 14(23):2835-43. PubMed ID: 9190900
    [Abstract] [Full Text] [Related]

  • 20. Taking myc to the max.
    Turner R.
    Nat Struct Biol; 2003 Mar 12; 10(3):157. PubMed ID: 12605219
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.